November 18, 2026 · Critical care medicine · DOI: 10.1097/CCM.0000000000007451

High-Flow Nasal Cannula Versus Conventional Oxygen Therapy in Adults With De Novo Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-Analysis With Trial Sequential Analysis.

Listen to this summary

This systematic review and meta-analysis of 13 randomized trials (4,294 adults) asked whether high-flow nasal cannula (HFNC) improves outcomes over conventional oxygen therapy (COT) in de novo acute hypoxemic respiratory failure. HFNC was associated with a modestly lower risk of intubation (RR 0.88, low certainty) but no significant difference in mortality (RR 0.96, moderate certainty), and trial sequential analysis found the evidence insufficient for a conclusive effect on either outcome. The authors conclude that HFNC may reduce the need for intubation but probably does not improve survival compared with COT.

Ping Lin, Xiaoqian Li, Yu Wang, Zongan Liang, Ting Wang

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play